Transporter Assays Using Solid Supported Membranes: A Novel Screening Platform for Drug Discovery

2006 ◽  
Vol 4 (5) ◽  
pp. 575-582 ◽  
Author(s):  
Bela Kelety ◽  
Kerstin Diekert ◽  
Joanna Tobien ◽  
Natalie Watzke ◽  
Wolfgang Dörner ◽  
...  
2013 ◽  
Vol 437 (4) ◽  
pp. 532-537 ◽  
Author(s):  
Daniela Morick ◽  
Michaela Schatz ◽  
Raphael Hubrich ◽  
Helen Hoffmeister ◽  
Anya Krefft ◽  
...  

2020 ◽  
Vol 25 (7) ◽  
pp. 770-782 ◽  
Author(s):  
Rebecca E. Hughes ◽  
Richard J. R. Elliott ◽  
Alison F. Munro ◽  
Ashraff Makda ◽  
J. Robert O’Neill ◽  
...  

Esophageal adenocarcinoma (EAC) is a highly heterogeneous disease, dominated by large-scale genomic rearrangements and copy number alterations. Such characteristics have hampered conventional target-directed drug discovery and personalized medicine strategies, contributing to poor outcomes for patients. We describe the application of a high-content Cell Painting assay to profile the phenotypic response of 19,555 compounds across a panel of six EAC cell lines and two tissue-matched control lines. We built an automated high-content image analysis pipeline to identify compounds that selectively modified the phenotype of EAC cell lines. We further trained a machine-learning model to predict the mechanism of action of EAC selective compounds using phenotypic fingerprints from a library of reference compounds. We identified a number of phenotypic clusters enriched with similar pharmacological classes, including methotrexate and three other antimetabolites that are highly selective for EAC cell lines. We further identify a small number of hits from our diverse chemical library that show potent and selective activity for EAC cell lines and that do not cluster with the reference library of compounds, indicating they may be selectively targeting novel esophageal cancer biology. Overall, our results demonstrate that our EAC phenotypic screening platform can identify existing pharmacologic classes and novel compounds with selective activity for EAC cell phenotypes.


MedChemComm ◽  
2019 ◽  
Vol 10 (6) ◽  
pp. 867-879 ◽  
Author(s):  
Urmila Maitra ◽  
Lukasz Ciesla

The review provides an overview of discovery of new drug leads from natural extracts usingDrosophilaas a screening platform to evaluate the therapeutic potential of phytochemicals against Parkinson's disease.


2009 ◽  
Vol 97 (1) ◽  
pp. 388-396 ◽  
Author(s):  
Patrick Schulz ◽  
Benjamin Dueck ◽  
Alexandre Mourot ◽  
Lina Hatahet ◽  
Klaus Fendler

2011 ◽  
Vol 64 (1) ◽  
pp. 31 ◽  
Author(s):  
Olga Gaiko ◽  
Ingo Janausch ◽  
Sven Geibel ◽  
Henning Vollert ◽  
Petra Arndt ◽  
...  

An electrophysiological assay platform based on solid supported membranes (SSM) for the organic cation transporter (OCT) is presented. Stable Chinese hamster ovary (CHO) cell lines overexpressing the human (hOCT2) and rat transporters (rOCT2) were generated and validated. Membrane preparations from the cell lines were investigated using SSM-based electrophysiology. Baculovirus transfected insect cells (HighFive and Mimic Sf9) were also tested with the same assay but yielded less than optimal results. The assays were validated by the determination of substrate affinities and inhibition by standard inhibitors. The study demonstrates the suitability of the SSM-based electrophysiological OCT assay for rapid and automatic screening of drug candidates.


Sign in / Sign up

Export Citation Format

Share Document